Published in Pharma Law Weekly, February 20th, 2007
This trend article about St. Louis University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Research findings, "CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels," are discussed in a new report. "CRSBP-1, a membrane glycoprotein, can mediate cell-surface retention of secreted growth factors containing CRS motifs such as PDGF-BB. CRSBP-1 has recently been found to be identical to LYVE-1, a specific marker for lymphatic capillary endothelial cells," scientists in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly